Antibody response in vaccinated pregnant mares to recent G3BP[12] and G14P[12] equine rotaviruses.
Abstract: Both the G3P[12] and the G14P[12] type of equine group A rotavirus (RVA) have recently become predominant in many countries, including Japan. G3 types are classified further into G3A and G3B. The G3A viruses have been circulating in Europe, Australia, and Argentina, and the G3B viruses have been circulating in Japan. However, only an inactivated vaccine containing a single G3BP[12] strain is commercially available in Japan. To assess the efficacy of the current vaccine against recently circulating equine RVA strains, we examined antibody responses in pregnant mares to recent G3BP[12] and G14P[12] strains by virus neutralization test. Results: After vaccination in five pregnant mares, the geometric mean serum titers of virus-neutralizing antibody to recent G3BP[12] strains increased 5.3- to 7.0-fold and were similar to that against homologous vaccine strain. Moreover, antibody titers to recent G14P[12] strains were also increased 3.0- to 3.5-fold. Conclusions: These results suggest that inoculation of mares with the current vaccine should provide foals with virus-neutralizing antibodies against not only the G3BP[12] but also the G14P[12] RVA strain via the colostrum.
Publication Date: 2012-11-06 PubMed ID: 23130609PubMed Central: PMC3523035DOI: 10.1186/1751-0147-54-63Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research paper investigates the effectiveness of a particular vaccine in pregnant horses against two prevalent types of equine A rotavirus. The study found that vaccination led to a significant increase in virus-neutralizing antibodies against both kinds of the virus, suggesting that the vaccine can also provide newly born foals with immunity through the mother’s colostrum.
Context and Objectives of the Research
- Two types of Group A Rotavirus (G3P[12] and G14P[12]) have become dominant in many nations, including Japan, causing concern in the equine industry.
- The variants of G3 are further classified into two categories: The G3A type is prevalent in Europe, Australia, and Argentina, whereas the G3B type is common in Japan. Unfortunately, the only commercially available vaccine in Japan contains a single G3BP[12] strain.
- Given this situation, the goal of the researchers was to determine whether this vaccine could effectively counteract the recently active strains of Equine RVA, thus providing the necessary information to make an informed decision regarding horse health management.
Methodology
- The researchers used a virus neutralization test to measure the antibody responses in five pregnant mares to recent G3BP[12] and G14P[12] strains following vaccination.
Results
- The results indicated a significant increase in the average virus-neutralizing antibody levels against the recent G3BP[12] strains, ranging from 5.3 to 7.0-fold. These results were comparable to the response against the specific strain in the vaccine.
- The antibody responses against recent G14P[12] strains also showed a notable rise, between 3.0- to 3.5-fold, indicating the vaccine’s potential efficacy against this strain.
Conclusions
- Based on these promising results, the researchers suggest that vaccinating mares with the current vaccine could provide not only protection against the G3BP[12] strain but also the G14P[12] RVA strain.
- Moreover, the immunity could potentially be passed on to foals via the colostrum, the first form of milk produced by the mother after birth which is rich in antibodies. This transfer of immunity from the mother to the offspring could help in preventing rotavirus infection in young horses which are particularly vulnerable to the disease.
Cite This Article
APA
Nemoto M, Tsunemitsu H, Murase H, Nambo Y, Sato S, Orita Y, Imagawa H, Bannai H, Tsujimura K, Yamanaka T, Matsumura T, Kondo T.
(2012).
Antibody response in vaccinated pregnant mares to recent G3BP[12] and G14P[12] equine rotaviruses.
Acta Vet Scand, 54(1), 63.
https://doi.org/10.1186/1751-0147-54-63 Publication
Researcher Affiliations
- Epizootic Research Center, Equine Research Institute, Japan Racing Association, 1400-4 Shiba, Shimotsuke, Tochigi 329-0412, Japan. nemoto_manabu@epizoo.equinst.go.jp
MeSH Terms
- Animals
- Antibodies, Viral / blood
- Antibodies, Viral / immunology
- Female
- Horse Diseases / immunology
- Horse Diseases / virology
- Horses
- Molecular Sequence Data
- Neutralization Tests / veterinary
- Phylogeny
- Polymerase Chain Reaction / veterinary
- Pregnancy
- Rotavirus / immunology
- Rotavirus Infections / immunology
- Rotavirus Infections / veterinary
- Rotavirus Infections / virology
- Rotavirus Vaccines / immunology
- Sequence Analysis, DNA / veterinary
- Vaccines, Inactivated / immunology
References
This article includes 28 references
- Estes MK, Kapikian AZ. Rotaviruses. Fields Virology 5. Philadelphia: Lippincott Williams & Wilkins; 2007; pp. 1917–1974.
- Imagawa H, Sekiguchi K, Anzai T, Fukunaga Y, Kanemaru T, Ohishi H, Higuchi T, Kamada M. Epidemiology of equine rotavirus infection among foals in the breeding region.. J Vet Med Sci 1991 Dec;53(6):1079-80.
- Matthijnssens J, Ciarlet M, Heiman E, Arijs I, Delbeke T, McDonald SM, Palombo EA, Iturriza-Gómara M, Maes P, Patton JT, Rahman M, Van Ranst M. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains.. J Virol 2008 Apr;82(7):3204-19.
- Elschner M, Schrader C, Hotzel H, Prudlo J, Sachse K, Eichhorn W, Herbst W, Otto P. Isolation and molecular characterisation of equine rotaviruses from Germany.. Vet Microbiol 2005 Jan 31;105(2):123-9.
- Collins PJ, Cullinane A, Martella V, O'Shea H. Molecular characterization of equine rotavirus in Ireland.. J Clin Microbiol 2008 Oct;46(10):3346-54.
- Ntafis V, Fragkiadaki E, Xylouri E, Omirou A, Lavazza A, Martella V. Rotavirus-associated diarrhoea in foals in Greece.. Vet Microbiol 2010 Aug 26;144(3-4):461-5.
- Garaicoechea L, Miño S, Ciarlet M, Fernández F, Barrandeguy M, Parreño V. Molecular characterization of equine rotaviruses circulating in Argentinean foals during a 17-year surveillance period (1992-2008).. Vet Microbiol 2011 Mar 24;148(2-4):150-60.
- Monini M, Biasin A, Valentini S, Cattoli G, Ruggeri FM. Recurrent rotavirus diarrhoea outbreaks in a stud farm, in Italy.. Vet Microbiol 2011 Apr 21;149(1-2):248-53.
- Browning GF, Chalmers RM, Fitzgerald TA, Snodgrass DR. Evidence for two serotype G3 subtypes among equine rotaviruses.. J Clin Microbiol 1992 Feb;30(2):485-91.
- Nemoto M, Tsunemitsu H, Imagawa H, Hata H, Higuchi T, Sato S, Orita Y, Sugita S, Bannai H, Tsujimura K, Yamanaka T, Kondo T, Matsumura T. Molecular characterization and analysis of equine rotavirus circulating in Japan from 2003 to 2008.. Vet Microbiol 2011 Aug 26;152(1-2):67-73.
- Tsunemitsu H, Imagawa H, Togo M, Shouji T, Kawashima K, Horino R, Imai K, Nishimori T, Takagi M, Higuchi T. Predominance of G3B and G14 equine group A rotaviruses of a single VP4 serotype in Japan.. Arch Virol 2001 Oct;146(10):1949-62.
- Matthijnssens J, Miño S, Papp H, Potgieter C, Novo L, Heylen E, Zeller M, Garaicoechea L, Badaracco A, Lengyel G, Kisfali P, Cullinane A, Collins PJ, Ciarlet M, O'Shea H, Parreño V, Bányai K, Barrandeguy M, Van Ranst M. Complete molecular genome analyses of equine rotavirus A strains from different continents reveal several novel genotypes and a largely conserved genotype constellation.. J Gen Virol 2012 Apr;93(Pt 4):866-875.
- Powell DG, Dwyer RM, Traub-Dargatz JL, Fulker RH, Whalen JW Jr, Srinivasappa J, Acree WM, Chu HJ. Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine.. J Am Vet Med Assoc 1997 Jul 15;211(2):193-8.
- Barrandeguy M, Parreño V, Lagos Mármol M, Pont Lezica F, Rivas C, Valle C, Fernandez F. Prevention of rotavirus diarrhoea in foals by parenteral vaccination of the mares: field trial.. Dev Biol Stand 1998;92:253-7.
- Imagawa H, Tanaka T, Sekiguchi K, Fukunaga Y, Anzai T, Minamoto N, Kamada M. Electropherotypes, serotypes, and subgroups of equine rotaviruses isolated in Japan.. Arch Virol 1993;131(1-2):169-76.
- Imagawa H, Kato T, Tsunemitsu H, Tanaka H, Sato S, Higuchi T. Field study of inactivated equine rotavirus vaccine. J Equine Sci 2005;16:35–44.
- Imagawa H, Wada R, Sugita S, Fukunaga Y. Passive immunity in foals of mares immunized with inactivated equine rotavirus vaccine. Equine Infectious Disease VIII Newmarket: R & W Publications; 1999; pp. 201–205.
- Imagawa H, Wada R, Hirasawa K, Akiyama Y, Oda T. Isolation of equine rotavirus in cell cultures from foals with diarrhea.. Nihon Juigaku Zasshi 1984 Feb;46(1):1-9.
- Shinozaki K, Yamanaka T, Tokieda M, Shirasawa H, Simizu B. Isolation and serial propagation of human group C rotaviruses in a cell line (CaCo-2).. J Med Virol 1996 Jan;48(1):48-52.
- Nemoto M, Imagawa H, Tsujimura K, Yamanaka T, Kondo T, Matsumura T. Detection of equine rotavirus by reverse transcription loop-mediated isothermal amplification (RT-LAMP).. J Vet Med Sci 2010 Jun;72(6):823-6.
- Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, Fang ZY. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.. J Clin Microbiol 1990 Feb;28(2):276-82.
- Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK. Identification of group A rotavirus gene 4 types by polymerase chain reaction.. J Clin Microbiol 1992 Jun;30(6):1365-73.
- Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.. Mol Biol Evol 2007 Aug;24(8):1596-9.
- Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Bányai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, Iturriza-Gómara M, Johne R, Kirkwood CD, Martella V, Mertens PP, Nakagomi O, Parreño V, Rahman M, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Patton JT, Desselberger U, Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG).. Arch Virol 2011 Aug;156(8):1397-413.
- Ojeh CK, Jiang BM, Tsunemitsu H, Kang SY, Weilnau PA, Saif LJ. Reactivity of monoclonal antibodies to the 41-kilodalton protein of porcine group C rotavirus with homologous and heterologous rotavirus serogroups in immunofluorescence tests.. J Clin Microbiol 1991 Sep;29(9):2051-5.
- Browning GF, Chalmers RM, Sale CS, Fitzgerald TA, Snodgrass DR. Homotypic and heterotypic serum and milk antibody to rotavirus in normal, infected and vaccinated horses.. Vet Microbiol 1991 May;27(3-4):231-44.
- Snodgrass DR, Fitzgerald TA, Campbell I, Browning GF, Scott FM, Hoshino Y, Davies RC. Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals.. J Clin Microbiol 1991 Nov;29(11):2668-72.
- Brüssow H, Walther I, Fryder V, Sidoti J, Bruttin A. Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus.. J Gen Virol 1988 Jul;69 ( Pt 7):1647-58.
Citations
This article has been cited 10 times.- Carossino M, Balasuriya UBR, Thieulent CJ, Barrandeguy ME, Vissani MA, Parreño V. Quadruplex Real-Time TaqMan(®) RT-qPCR Assay for Differentiation of Equine Group A and B Rotaviruses and Identification of Group A G3 and G14 Genotypes. Viruses 2023 Jul 26;15(8).
- Nemoto M, Matsumura T. Equine rotavirus infection. J Equine Sci 2021 Mar;32(1):1-9.
- Carossino M, Barrandeguy ME, Erol E, Li Y, Balasuriya UBR. Development and evaluation of a one-step multiplex real-time TaqMan(®) RT-qPCR assay for the detection and genotyping of equine G3 and G14 rotaviruses in fecal samples. Virol J 2019 Apr 25;16(1):49.
- Matthijnssens J, Ons E, De Coster S, Conceição-Neto N, Gryspeerdt A, Van Ranst M, Raue R. Molecular characterization of equine rotaviruses isolated in Europe in 2013: implications for vaccination. Vet Microbiol 2015 Mar 23;176(1-2):179-85.
- Nemoto M, Bannai H, Tsujimura K, Yamanaka T, Kondo T. Virucidal effect of commercially available disinfectants on equine group A rotavirus. J Vet Med Sci 2014 Jul;76(7):1061-3.
- Bailey KE, Gilkerson JR, Browning GF. Equine rotaviruses--current understanding and continuing challenges. Vet Microbiol 2013 Nov 29;167(1-2):135-44.
- Cullinane A, Garvey M, Dayot L, Lukaseviciute G. Equine Rotavirus A Outbreaks in Ireland (2023-2024): An Epidemiological Investigation and Virus Genotyping. Viruses 2025 Mar 31;17(4).
- Ghonaim AH, Rouby SR, Nageeb WM, Elgendy AA, Xu R, Jiang C, Ghonaim NH, He Q, Li W. Insights into recent advancements in human and animal rotavirus vaccines: Exploring new frontiers. Virol Sin 2025 Feb;40(1):1-14.
- Uprety T, Soni S, Sreenivasan C, Hause BM, Naveed A, Ni S, Graves AJ, Morrow JK, Meade N, Mellits KH, Adam E, Kennedy MA, Wang D, Li F. Genetic and antigenic characterization of two diarrhoeicdominant rotavirus A genotypes G3P[12] and G14P[12] circulating in the global equine population. J Gen Virol 2024 Aug;105(8).
- Carossino M, Vissani MA, Barrandeguy ME, Balasuriya UBR, Parreño V. Equine Rotavirus A under the One Health Lens: Potential Impacts on Public Health. Viruses 2024 Jan 16;16(1).
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists